Demographic and hematologic characteristics of study participants
| . | Patients (n = 30) . | Healthy individuals (n = 30) . | P . |
|---|---|---|---|
| Age, y | 52.7 ± 12.3 | 50.3 ± 9.2 | .40 |
| Male/female ratio | 16:14 | 16:14 | 1.00 |
| Hemoglobin, g/dL | 13.96 ± 1.91 | 14.30 ± 1.11 | .42 |
| Leukocytes, 109/L | 8.04 ± 3.91 | 5.58 ± 1.58 | .004 |
| Neutrophils, 109/L | 6.38 ± 3.77 | 3.09 ± 0.93 | <.001 |
| Lymphocytes, 109/L | 1.20 ± 0.55 | 1.79 ± 0.28 | <.001 |
| Monocytes, 109/L | 0.51 ± 0.30 | 0.34 ± 0.11 | .047 |
| Platelets, 109/L | 216.33 ± 93.02 | 245.59 ± 40.34 | .12 |
| NLR | 6.19 ± 4.26 | 1.72 ± 0.61 | <.001 |
| . | Patients (n = 30) . | Healthy individuals (n = 30) . | P . |
|---|---|---|---|
| Age, y | 52.7 ± 12.3 | 50.3 ± 9.2 | .40 |
| Male/female ratio | 16:14 | 16:14 | 1.00 |
| Hemoglobin, g/dL | 13.96 ± 1.91 | 14.30 ± 1.11 | .42 |
| Leukocytes, 109/L | 8.04 ± 3.91 | 5.58 ± 1.58 | .004 |
| Neutrophils, 109/L | 6.38 ± 3.77 | 3.09 ± 0.93 | <.001 |
| Lymphocytes, 109/L | 1.20 ± 0.55 | 1.79 ± 0.28 | <.001 |
| Monocytes, 109/L | 0.51 ± 0.30 | 0.34 ± 0.11 | .047 |
| Platelets, 109/L | 216.33 ± 93.02 | 245.59 ± 40.34 | .12 |
| NLR | 6.19 ± 4.26 | 1.72 ± 0.61 | <.001 |
Data are given as mean ± standard deviation unless otherwise indicated.
NLR, neutrophil/lymphocyte ratio.